Completed OBSERVATIONAL NCT00448487

Haptoglobin Phenotype and Cardiovascular Complications in Diabetic Patients (ICARER)

Prospective Observational Study to Asses the Incidence of CVD Complications in Diabetic Patients Pre-stratified by Haptoglobin Phenotype From the I CARE Registry

Sponsor: Clalit Health Services

Conditions Cardiovascular Disease Diabetes Myocardial Infarction

Updated 6 times since 2017 Last updated: Jun 10, 2015 Started: Apr 30, 2005 Primary completion: Jun 30, 2008 Completion: Jun 30, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00448487, this observational or N/A phase trial focuses on Cardiovascular Disease and Diabetes and remains completed. Sponsored by Clalit Health Services, it has been updated 6 times since 2005, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Apr 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Clalit Health Services
Dr. Shany Blum

Data source: Technion, Israel Institute of Technology

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Haifa, Israel